Savant Capital LLC decreased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 3.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 107,120 shares of the medical device company’s stock after selling 3,941 shares during the […]